Live Breaking News & Updates on மீ மருந்துகள்

Stay updated with breaking news from மீ மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine The


Search jobs
08-Apr-2021
Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine Therapy for Patients with ER+/HER2- Metastatic Breast Cancer and Provides Corporate Update
Preliminary Phase 1b Data
- Gedatolisib showed a potentially differentiated safety and tolerability profile -
Corporate Update
- Proceeds from first $15 million tranche increase cash-on-hand to $44 million -
- Drug development capabilities and team broadened and expanded -
- Conference call and webcast scheduled for today, April 8 at 5 p.m. Eastern Time -
MINNEAPOLIS (BUSINESS WIRE) Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating patients with cancer, today reported preliminary data for the 103 patients enrolled in the expansion portion of an ongoing Phase 1b clinical trial evaluating ged ....

Sheri Smith , Bernhard Lampert , Celsignia Cdx , Arthur Decillis , Bristol Myers Squibb , Vicky Hahne , Marie Degayner Kuker , Robert Uhl , Johnr Macdonald , Brian Sullivan , Regulatory Affairs Professionals Society , Exchange Commission On , Eisai Co , Vp Clinical Research For Exelixis , University Of Georgia , Celcuity Inc , Armentum Partners , Sesen Bio Inc , Wm Pharmaceuticals , Innovatus Capital Partners , Preliminary Phase , Response Evaluation Criteria , Solid Tumors , Chief Medical , Chief Medical Officer , Senior Vice President ,

Investigations Newsletter: Pharmacy Owner and Accountant Indicted in $134m Health Care Fraud Scheme | Arent Fox


Headlines that Matter for Companies and Executives in Regulated Industries
Pharmacy Owner and Accountant Indicted in $134m Health Care Fraud Scheme
Mohamed Mokbel and Fathy Elsafty, of Houston, Texas, were arrested on charges of money laundering, health care fraud, and conspiracy to commit health care fraud for their participation in an alleged pharmacy fraud scheme.
Mokbel served as CEO of 4M Pharmaceuticals, Inc., the parent company of several retail pharmacies that operated in Texas and Florida, and Elsafty was 4M Pharmaceutical’s accountant and tax preparer. Both individuals had ownership interests in the retail pharmacies.
According to the indictment, 4M Pharmaceutical employees operated as call center employees to solicit Medicare, Medicaid, and commercial insurance patients nationwide by offering patients medically unnecessary diabetic supplies and topical creams. Even though many patients rebuffed the solicitation attempts, 4M Pharmaceuticals and its subs ....

United States , San Antonio , Dmitry Royzman , Mohamed Mokbel , Hugoa Rojas , Fathy Elsafty , Housing Choice Voucher Program , Health Care Fraud Scheme , M Pharmaceuticals Inc , Us Department Of Housing , Wm Pharmaceuticals , Pharmacy Owner , Accountant Indicted , Health Care Fraud , Agrees To Pay , Resolve False Claims Act , Controlled Substances Act , False Claims Act , Controlled Substances , Urban Development , ஒன்றுபட்டது மாநிலங்களில் , சான் அன்டோனியோ , வீட்டுவசதி தேர்வு வவுச்சர் ப்ரோக்ர்யாம் , ஆரோக்கியம் பராமரிப்பு மோசடி திட்டம் , மீ மருந்துகள் இன்க் , எங்களுக்கு துறை ஆஃப் வீட்டுவசதி ,